Scientific and Medical Equipment House Company (TADAWUL:4014)

TADAWUL:4014 Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	80.36	20.47	88.06	16.95	54.56	45.32
Cash & Short-Term Investments	80.36	20.47	88.06	16.95	54.56	45.32
Cash Growth	194.64%	-76.75%	419.62%	-68.94%	20.38%	-48.87%
Accounts Receivable	722.66	707.8	609.89	810.42	605.22	712.11
Other Receivables	6.23	5.16	6.99	6.87	12.64	4.7
Receivables	728.9	712.96	616.89	817.29	617.86	716.81
Inventory	55.75	65.85	103.21	105.03	97.68	97.24
Prepaid Expenses	56.33	25.97	27.48	38.03	37.85	38.57
Other Current Assets	-	29.32	34.58	24.83	26.52	43.73
Total Current Assets	921.34	854.57	870.22	1,002	834.47	941.68
Property, Plant & Equipment	38.15	41.24	46.24	62.07	57.24	43.82
Long-Term Investments	12.85	-	-	-	-	-
Other Intangible Assets	1.12	1.24	0.97	2.5	3.69	-
Other Long-Term Assets	35.25	36.35	34.34	37.34	35.63	32.33
Total Assets	1,009	933.4	951.76	1,104	931.03	1,018

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	60.76	47.99	56.25	49.73	68.49	65.11
Accrued Expenses	122.15	60.32	61.21	67.75	73.08	124.41
Short-Term Debt	202.93	170.22	185.14	332.27	177.88	248.01
Current Portion of Long-Term Debt	6.5	1.75	1.55	1.25	0.16	0.5
Current Portion of Leases	6.28	6.98	5.68	9.47	8.23	4.74
Current Income Taxes Payable	11.46	16.59	15.01	15.46	12.16	6.93
Current Unearned Revenue	17.9	38.31	27.08	23.93	27.75	5.61
Other Current Liabilities	-	7.68	8.99	9.5	10.75	19.04
Total Current Liabilities	427.98	349.85	360.91	509.35	378.51	474.35
Long-Term Debt	10.75	5.03	6.78	8.33	9.67	7.23
Long-Term Leases	6.2	7.52	9.01	11.52	10.61	5.77
Pension & Post-Retirement Benefits	73.78	70.16	70.08	68.08	63.61	56.8
Total Liabilities	518.72	432.56	446.78	597.28	462.4	544.15

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	300	300	300	300	200	200
Retained Earnings	197.85	208.69	210.61	210.77	270.37	273.46
Comprehensive Income & Other	0.85	-	-	-	-	-
Total Common Equity	498.71	508.69	510.61	510.77	470.37	473.46
Minority Interest	-8.72	-7.84	-5.62	-4	-1.74	0.22
Shareholders' Equity	489.99	500.84	504.99	506.77	468.63	473.68
Total Liabilities & Equity	1,009	933.4	951.76	1,104	931.03	1,018

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	232.66	191.5	208.15	362.83	206.56	266.24
Net Cash (Debt)	-152.3	-171.03	-120.09	-345.88	-152	-220.92
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-5.08	-5.70	-4.00	-11.53	-5.07	-7.36
Filing Date Shares Outstanding	30	30	30	30	30	30
Total Common Shares Outstanding	30	30	30	30	30	30
Working Capital	493.35	504.72	509.31	492.79	455.95	467.33
Book Value Per Share	16.62	16.96	17.02	17.03	15.68	15.78
Tangible Book Value	497.58	507.44	509.64	508.27	466.68	473.46
Tangible Book Value Per Share	16.59	16.91	16.99	16.94	15.56	15.78
Buildings	-	0.62	0.59	0.59	0.68	0.68
Machinery	-	98.84	98.7	98.2	87.59	76.35
Leasehold Improvements	-	7.53	7.39	9.65	9.56	8.01

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error